From life-saving cancer treatments, to highly sophisticated diagnostic imaging equipment, to allergy testing equipment, to helping doctors and hospitals better manage patient data, Hitachi is dedicated to improving healthcare and medical treatment.
Among its many healthcare-related accomplishments, Hitachi is a pioneer in proton beam therapy (PBT) technology, an advanced type of cancer radiotherapy that employs spot scanning irradiation. In 1998, Hitachi developed its own proton beam therapy system, and in 2001, the first Hitachi PBT system was successfully used at the University of Tsukuba in Japan.
In addition to PBT, Hitachi’s healthcare companies provide many other cutting edge technologies, including medical imaging, medical diagnostics, patient monitoring systems, performance improvement, drug discovery and biopharmaceutical manufacturing technologies. These technologies are helping clinicians around the world create the next generation of products to predict, diagnose and treat disease so their patients can live their lives to the fullest.
Hitachi Aloka Medical America, Inc. is committed to delivering advanced diagnostic ultrasound systems to meet the needs of physicians and patients. As the longest operating ultrasound company in the world Hitachi Aloka Medical has led the medical industry by pioneering ultrasound systems that have advanced the standard of real time imaging. It designs and develops innovative consoles, transducers, software and related products that are used to help medical professionals deliver proactive solutions to diagnose and treat patients and deliver the best patient care possible.
Having made significant and noteworthy contributions in the field of ultrasound technology, including introducing the world’s first commercialized medical ultrasound equipment back in 1960, Hitachi Aloka Medical is poised to continue the advancement of its ultrasound business. In 2011, Hitachi Aloka Medical, Inc. introduced yet another first with the robotically-controlled ultrasound transducer giving surgeons direct control of the real-time imaging during minimally invasive Robotic Partial Nephrectomy (RAPN) procedures.
With its international headquarters in Tokyo, Japan, Hitachi Aloka Medical, Ltd. encompasses the ultrasound division of both Hitachi Medical Corporation and Aloka Co., Ltd. The company centralized its U.S. and Canada business operations in Wallingford, CT, and Hitachi Aloka Medical America, Inc. employs local sales, service and clinical applications professionals across the U.S. and Canada.
In 2006, Hitachi obtained FDA clearance to sell its Proton Beam Therapy (PBT) system in the U. S. This product is sold and marketed by Hitachi America, Ltd.’s Power Systems Division. PBT is gaining popularity due to its effectiveness in treating certain forms of cancer by delivering targeted doses of radiation to cancerous tumors with less damage to surrounding, healthy tissue. With this treatment, patients experience minimal pain during the procedure and are able to maintain their normal, daily activities while also effectively treating their disease. Hitachi has over 20 years of proven particle technology experience, consisting of designing, manufacturing and implementing key particle accelerating components and technologies at various internationally recognized cancer treatment centers of excellence, including The University of Texas MD Anderson Cancer Center in Houston, TX.
Hitachi Chemical Diagnostics (HCD) - a subsidiary of Hitachi Chemical America, Cupertino, CA – is headquartered in the heart of Silicon Valley in Mountain View, California. HCD is a global leader of FDA-Cleared and CE Marked multiplex in vitro allergy diagnostic systems, and recently launched ExoComplete™, a complete system for exosome collection to mRNA purification – a “Research Use Only” product. The company holds many patents, works with industry leaders, laboratories, and distributors in more than 40 countries, and continues to pioneer advancements in the healthcare industry.
Hitachi Chemical Research Center, Inc. (HCR), a wholly-owned subsidiary of Hitachi Chemical Company, is a research and development company performing cutting edge research in the life sciences field. Utilizing their expertise in mRNA research, HCR scientists are developing new diagnostic tools to determine drug efficacy and help with genetic testing. In addition, HCR’s nanotechnology group develops chemical and electrochemical technologies and materials designed to improve the health and welfare of people around the world.
Hitachi Data Systems (HDS) provides best-inclass information technologies, services and solutions that help store and protect sensitive medical data, improve clinical decision making and the resulting patient care, and control costs. They are focused on helping healthcare providers, payers and life sciences organizations transform their businesses, lower costs and ultimately transform life. HDS solutions for healthcare providers meet changing clinical and business demands while improving patient safety, team productivity and quality of care. Its healthcare payer solutions enhance processing and payment systems performance. And the company’s medical solutions – such as Hitachi Clinical Repository (HCR), an information management solution that transforms raw medical data and images into meaningful information, independent of the source application – are designed to enhance collaboration and information mobility.
Hitachi Medical Systems America, Inc., located in Twinsburg, OH, is a wholly-owned subsidiary of Hitachi Medical Corporation and offers a broad range of patient-friendly diagnostic imaging equipment, including MRI & CT. Our innovations in diagnostic imaging provide technology that drives clinical solutions to deliver diagnostic confidence, improve workflow efficiency and deliver a better patient experience. In addition to exceptional equipment, HMSA is known for its comprehensive customer support programs that maximize the lifecycle value of equipment through responsive service maintenance, significant software upgrades and ongoing applications support.
HMSA pioneered the Open MRI and is known for its many innovations in diagnostic imaging, including its lower dose, high diagnostic value CT solutions, patientfriendly high-field MRI and next generation Ultrasound systems.